GYRE THERAPEUTICS, INC. — Director's Dealing 2014

Jun 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TARGACEPT INC (TRGT)
CIK: 0001124105
Period of Report: 2014-06-12

Reporting Person: DESOUZA ERROL B (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-12	Stock Option (Right to Buy)	$4.29	A	12500	Acquired	2024-06-11	Common Stock (12500)	Direct

Footnotes

F1: This stock option vests and becomes exercisable in full on the earlier of (i) June 12, 2015 or (ii) the business day immediately preceding the date of the issuer's annual meeting of stockholders that occurs in 2015, provided that the reporting person remains in service as a director on such earlier date.